Business Wire (press release)
Sciele Pharma and Plethora Solutions Announce Positive Phase III …
Business Wire (press release), CA - Nov 7, 2008
There are currently no approved pharmaceutical treatments for premature ejaculation. PSD502 is applied locally "on demand" and is effective within five …
Plethora: Plethora reports positive outcomes of European Phase III … Proactive Investors UK
all 14 news articles